ReviewFrontiers in microbiology2026
Advances in antibiofilm strategies for medical implant-associated infections: emerging technologies and translational challenges.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical implants are instrumental for modern diagnosis, treatment, and management of disease. However, their increased usage has also raised concerns about implant associated infections. These infections are predominantly caused by microbial biofilms, conferring enhanced resistance to antimicrobial therapies, host immune responses, and environmental stresses, making infections difficult to eradicate. This review provided an updated overview of the evolving antibiofilm landscape for medical implants. It discusses major biofilm forming pathogens and mechanisms of biofilm development, followed by conventional and emerging approaches for biofilm prevention and eradication, including antifouling and antimicrobial coatings, quorum sensing inhibitors, hybrid or multifunctional or combination coatings, antimicrobial peptides, nanotechnology enabled platforms, photodynamic and photothermal therapies, immune targeting strategies, and smart coatings. The review further underscores the challenges associated with these antibiofilm strategies hindering clinical translation. Combating these challenges will play a crucial role in the future, improving antibiofilm therapies and patient outcomes in biofilm related medical implant infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.